Your browser doesn't support javascript.
loading
Psychopharmacologic Treatment of Depression in Patients with Medical Illness / 대한정신약물학회지
Article de Ko | WPRIM | ID: wpr-45311
Bibliothèque responsable: WPRO
ABSTRACT
While in the past the almost sole availability of tricyclic antidepressants had limited antidepressant drug selection, newer drugs such as selective serotonin reuptake inhibitors, bupropion, mirtazapine and venlafaxine have vastly simplified treating depression in patients with medical illness. Appropriate selection of an antidepressant agent in medically ill patients requires a careful risk-benefit assessment of the antidepressant treatment considering the pharmacokinetic and pharmacodynamic properties of drugs, potential for drug interaction, the patient's general medical conditions, and primary symptoms of the patient's depression. The effective and safe approach to antidepressant treatment is to reduce initial dosage, to titrate upward more slowly, and to monitor closely adverse effects in patients with medical illness.
Sujet(s)
Mots clés
Texte intégral: 1 Indice: WPRIM Sujet Principal: Bupropion / Inbiteurs sélectifs de la recapture de la sérotonine / Appréciation des risques / Dépression / Interactions médicamenteuses / Chlorhydrate de venlafaxine / Antidépresseurs tricycliques Type d'étude: Etiology_studies / Risk_factors_studies Limites du sujet: Humans langue: Ko Texte intégral: Korean Journal of Psychopharmacology Année: 2005 Type: Article
Texte intégral: 1 Indice: WPRIM Sujet Principal: Bupropion / Inbiteurs sélectifs de la recapture de la sérotonine / Appréciation des risques / Dépression / Interactions médicamenteuses / Chlorhydrate de venlafaxine / Antidépresseurs tricycliques Type d'étude: Etiology_studies / Risk_factors_studies Limites du sujet: Humans langue: Ko Texte intégral: Korean Journal of Psychopharmacology Année: 2005 Type: Article